Worldwide Duchenne Muscular Dystrophy Drug Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Duchenne Muscular Dystrophy Drug by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Duchenne Muscular Dystrophy Drug Market-Segmentation

4.1 By Type

4.1.1 Steroid Therapy

4.1.2 Exon Skipping

4.1.3 Mutation Suppression

4.2 By End-User/Application Industry

4.2.1 Translarna

4.2.2 Emflaza

4.2.3 EXONDYS 51

4.3 By Geography

4.3.1 North America Duchenne Muscular Dystrophy Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Duchenne Muscular Dystrophy Drug Production from 2014-2020

4.3.1.2 North America Duchenne Muscular Dystrophy Drug Consumption from 2014-2020

4.3.1.3 North America Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

4.3.1.4 North America Duchenne Muscular Dystrophy Drug Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Duchenne Muscular Dystrophy Drug Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Duchenne Muscular Dystrophy Drug Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Duchenne Muscular Dystrophy Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Duchenne Muscular Dystrophy Drug Production from 2014-2020

4.3.2.2 Europe Duchenne Muscular Dystrophy Drug Consumption from 2014-2020

4.3.2.3 Europe Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

4.3.2.4 Europe Duchenne Muscular Dystrophy Drug Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Duchenne Muscular Dystrophy Drug Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Duchenne Muscular Dystrophy Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Duchenne Muscular Dystrophy Drug Production from 2014-2020

4.3.3.2 Asia-Pacific Duchenne Muscular Dystrophy Drug Consumption from 2014-2020

4.3.3.3 Asia-Pacific Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Duchenne Muscular Dystrophy Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Duchenne Muscular Dystrophy Drug Production from 2014-2020

4.3.4.2 Latin America Duchenne Muscular Dystrophy Drug Consumption from 2014-2020

4.3.4.3 Latin America Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

4.3.4.4 Latin America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Duchenne Muscular Dystrophy Drug Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Duchenne Muscular Dystrophy Drug Production from 2014-2020

4.3.5.2 Middle East & Africa Duchenne Muscular Dystrophy Drug Consumption from 2014-2020

4.3.5.3 Middle East & Africa Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Nippon Shinyaku

5.1.1 Nippon Shinyaku Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Nippon Shinyaku Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Santhera Pharmaceuticals

5.2.1 Santhera Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Santhera Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Janssen Pharmaceuticals

5.3.1 Janssen Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Janssen Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.4 PTC Therapeutics

5.4.1 PTC Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 PTC Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Acceleron Pharma

5.5.1 Acceleron Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Acceleron Pharma Sales, Growth Rate and Global Market Share from 2014-2020

5.6 BioMarin Pharmaceutical

5.6.1 BioMarin Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 BioMarin Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Nobelpharma

5.7.1 Nobelpharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Nobelpharma Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Sarepta Therapeutics

5.8.1 Sarepta Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Sarepta Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Pfizer

5.9.1 Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Lexicon Pharmaceuticals

5.10.1 Lexicon Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Lexicon Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.11 Summit Therapeutics

5.11.1 Summit Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.11.2 Summit Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.12 Asklepios BioPharmaceuticals

5.12.1 Asklepios BioPharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.12.2 Asklepios BioPharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.13 Eli Lilly

5.13.1 Eli Lilly Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.13.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2014-2020

5.14 Akashi Therapeutics

5.14.1 Akashi Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.14.2 Akashi Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.15 Capricor Therapeutics

5.15.1 Capricor Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.15.2 Capricor Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.16 Marathon Pharmaceuticals

5.16.1 Marathon Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.16.2 Marathon Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.17 Bristol-Myers Squibb

5.17.1 Bristol-Myers Squibb Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.17.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2014-2020

5.18 Catabasis Pharmaceuticals

5.18.1 Catabasis Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.18.2 Catabasis Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Duchenne Muscular Dystrophy Drug Market from 2021-2026

7.1 Future Forecast of Global Duchenne Muscular Dystrophy Drug Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Duchenne Muscular Dystrophy Drug Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Duchenne Muscular Dystrophy Drug Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

Global Duchenne Muscular Dystrophy Drug Market Value ($) and Growth Rate of Duchenne Muscular Dystrophy Drug from 2014-2026

Global Duchenne Muscular Dystrophy Drug Production and Growth Rate Segment by Product Types from 2014-2026F

Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Duchenne Muscular Dystrophy Drug Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Duchenne Muscular Dystrophy Drug Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Steroid Therapy of Duchenne Muscular Dystrophy Drug

Figure Exon Skipping of Duchenne Muscular Dystrophy Drug

Figure Mutation Suppression of Duchenne Muscular Dystrophy Drug

Table Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Duchenne Muscular Dystrophy Drug Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Translarna of Duchenne Muscular Dystrophy Drug

Figure Emflaza of Duchenne Muscular Dystrophy Drug

Figure EXONDYS 51 of Duchenne Muscular Dystrophy Drug

Table Global Duchenne Muscular Dystrophy Drug Production Value ($) by Regions

Table Global Duchenne Muscular Dystrophy Drug Production Value Share by Regions

Table Global Duchenne Muscular Dystrophy Drug Production by Regions

Table Global Duchenne Muscular Dystrophy Drug Production Share by Regions

Table Global Duchenne Muscular Dystrophy Drug Consumption by Regions

Table Global Duchenne Muscular Dystrophy Drug Consumption Share by Regions

Figure North America Duchenne Muscular Dystrophy Drug Production and Growth Rate from 2014-2020

Figure North America Duchenne Muscular Dystrophy Drug Consumption and Growth Rate from 2014-2020

Table North America Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

Table North America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

Table North America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

Table North America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

Figure Europe Duchenne Muscular Dystrophy Drug Production and Growth Rate from 2014-2020

Figure Europe Duchenne Muscular Dystrophy Drug Consumption and Growth Rate from 2014-2020

Table Europe Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

Table Europe Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

Table Europe Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

Table Europe Duchenne Muscular Dystrophy Drug Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Duchenne Muscular Dystrophy Drug Production and Growth Rate from 2014-2020

Figure Asia-Pacific Duchenne Muscular Dystrophy Drug Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

Table Asia-Pacific Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

Figure Latin America Duchenne Muscular Dystrophy Drug Production and Growth Rate from 2014-2020

Figure Latin America Duchenne Muscular Dystrophy Drug Consumption and Growth Rate from 2014-2020

Table Latin America Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

Table Latin America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Duchenne Muscular Dystrophy Drug Production and Growth Rate from 2014-2020

Figure Middle East & Africa Duchenne Muscular Dystrophy Drug Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Duchenne Muscular Dystrophy Drug Import and Export from 2014-2020

Table Middle East & Africa Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Duchenne Muscular Dystrophy Drug Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Duchenne Muscular Dystrophy Drug Participants Value ($) and Market Share (%) in 2019

Table Nippon Shinyaku Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Nippon Shinyaku Sales and Growth Rate from 2014-2020

Figure Nippon Shinyaku Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Santhera Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Santhera Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Santhera Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Janssen Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Janssen Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Janssen Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table PTC Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure PTC Therapeutics Sales and Growth Rate from 2014-2020

Figure PTC Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Acceleron Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Acceleron Pharma Sales and Growth Rate from 2014-2020

Figure Acceleron Pharma Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table BioMarin Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure BioMarin Pharmaceutical Sales and Growth Rate from 2014-2020

Figure BioMarin Pharmaceutical Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Nobelpharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Nobelpharma Sales and Growth Rate from 2014-2020

Figure Nobelpharma Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sarepta Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sarepta Therapeutics Sales and Growth Rate from 2014-2020

Figure Sarepta Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Sales and Growth Rate from 2014-2020

Figure Pfizer Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Lexicon Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Lexicon Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Lexicon Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Summit Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Summit Therapeutics Sales and Growth Rate from 2014-2020

Figure Summit Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Asklepios BioPharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Asklepios BioPharmaceuticals Sales and Growth Rate from 2014-2020

Figure Asklepios BioPharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Eli Lilly Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Eli Lilly Sales and Growth Rate from 2014-2020

Figure Eli Lilly Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Akashi Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Akashi Therapeutics Sales and Growth Rate from 2014-2020

Figure Akashi Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Capricor Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Capricor Therapeutics Sales and Growth Rate from 2014-2020

Figure Capricor Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Marathon Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Marathon Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Marathon Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Bristol-Myers Squibb Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Bristol-Myers Squibb Sales and Growth Rate from 2014-2020

Figure Bristol-Myers Squibb Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Catabasis Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Catabasis Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Catabasis Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Duchenne Muscular Dystrophy Drug Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Duchenne Muscular Dystrophy Drug Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Duchenne Muscular Dystrophy Drug Production and Growth Rate Forecast by Types (2021-2026)

Table Global Duchenne Muscular Dystrophy Drug Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)